Search Results for "Zonegran"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Zonegran. Results 1 to 7 of 7 total matches.
See also: zonisamide

Zonisamide (Zonegran) For Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Oct 02, 2000  (Issue 1089)
Zonisamide (Zonegran) For Epilepsy ...
Zonisamide (Zonegran - Elan Pharma), a sulfonamide chemically unrelated to other antiepileptic drugs, has been approved by the FDA for adjunctive use in adults with partial seizures. Zonisamide has been available in Japan for more than 10 years.
Med Lett Drugs Ther. 2000 Oct 2;42(1089):94-5 |  Show IntroductionHide Introduction

Two New Drugs for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Apr 17, 2000  (Issue 1076)
. A third drug, zonisamide (Zonegran − Elan) has just been approved by the FDA for add-on therapy in adults ...
Oxcarbazepine, which is chemically similar to carbamazepine, and levetiracetam, a pyrrolidine acetamide chemically unrelated to other antiepileptic drugs, are the sixth and seventh drugs approved by the US Food and Drug Administration in the last five years for oral use in partial seizures.
Med Lett Drugs Ther. 2000 Apr 17;42(1076):33-5 |  Show IntroductionHide Introduction

Ezogabine (Potiga) for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Aug 20, 2012  (Issue 1397)
100-400 mg in 1-2 14.70 Zonegran (Eisai) 25, 100 mg caps divided doses 123.90 ER = extended release ...
The FDA has approved ezogabine (ee-ZOE-ga-been; Potiga – GSK/Valeant) for oral adjunctive treatment of partial-onset seizures in adults. Ezogabine is available in Europe as retigabine (Trobalt).
Med Lett Drugs Ther. 2012 Aug 20;54(1397):65-7 |  Show IntroductionHide Introduction

Lacosamide for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Jun 29, 2009  (Issue 1315)
100-400 mg 56.70 Zonegran (Eisai) 25, 100 mg caps 93.60 1. Cost for 30 days’ treatment ...
The FDA has approved lacosamide (Vimpat - UCB Pharma) for oral or intravenous (IV) use as add-on therapy in adults with partial-onset seizures.
Med Lett Drugs Ther. 2009 Jun 29;51(1315):50-2 |  Show IntroductionHide Introduction

Vigabatrin (Sabril) for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Feb 22, 2010  (Issue 1332)
-6400 mg 10-15 mg/kg 25-40 mg/kg 6 tid Zonisamide 4 (Zonegran ...
The FDA has approved vigabatrin (vye gá ba trin; Sabril – Lundbeck) for oral use as add-on therapy for complex partial seizures in adults who are refractory to several antiepileptic drugs and as monotherapy for infantile spasms. Vigabatrin has been available in other countries for many years. Because of its potential for retinal toxicity, it will be available in the US only through a restricted distribution program called SHARE (Support, Help and Resources for Epilepsy). Prescribers and pharmacists distributing the drug must register, and patients must undergo visual field testing.
Med Lett Drugs Ther. 2010 Feb 22;52(1332):14-6 |  Show IntroductionHide Introduction

Drugs for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
Not approved for patients 16.80 Zonegran (Concordia) 25, 100 mg caps or in 2 divided doses ...
When used for the appropriate seizure type, antiseizure medications (ASMs) are roughly equivalent in efficacy. In addition to the seizure type, the choice of drug is usually based on factors such as ease of use, spectrum of activity, adverse effects, interactions with other drugs, presence of comorbid conditions, suitability for elderly persons and those with childbearing potential, and cost. Treatment should begin with a single drug, increasing the dosage gradually until seizures are controlled or adverse effects become unacceptable. If seizures persist, expert clinicians generally...
Med Lett Drugs Ther. 2024 Aug 5;66(1708):121-8   doi:10.58347/tml.2024.1708a |  Show IntroductionHide Introduction

Comparison Table: Some Oral Antiseizure Medications (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
-clonic, absence, atypical absence, myoclonic, and atonic seizures 16.80 Zonegran (Concordia) 25, 100 ...
View the Comparison Table: Some Oral Antiseizure Medications
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e133-40   doi:10.58347/tml.2024.1708b |  Show IntroductionHide Introduction